IR Licensing and Partnerships

Latest News

June 16th 2025

AstraZeneca, CSPC Launch AI-Powered Collaboration for Oral Drug Discovery

Under terms of the deal, CSPC will receive $110 million upfront, with potential milestone payments reaching up to $5.22 billion, in addition to single-digit royalties.

June 12th 2025

GSK Licenses altSonflex1-2-3 Shigella Vaccine to Bharat Biotech

By Don Tracy, Associate Editor

February 13th 2025

Novartis Strikes Deal to Acquire Anthos Therapeutics

By Don Tracy, Associate Editor

February 12th 2025

Abcuro Secures $200 Million in Series C Funding to Advance Ulviprubart for Inclusion Body Myositis

By Don Tracy, Associate Editor

January 30th 2025

ImmunityBio, BeiGene Strike Deal to Conduct Phase III Trial for Tislelizumab, Anktiva in Advanced or Metastatic Non-Small Cell Lung Cancer

By Don Tracy, Associate Editor

IR Licensing and Partnerships

Latest News

Trending on PharmExec

Eli Lilly Breaks Ground on $3.5 billion Pennsylvania Manufacturing Site

Building Connected AI Ecosystems, Not Standalone Tools

Where AI Is Having the Most Impact and Where Gaps Remain

FDA Pauses Commissioner’s National Priority Voucher Program: Report

Moderna Lays Out Oncology-Driven Growth Plan at 2026 Analyst Day